Resolutions of the 31st Ordinary General Meeting of DocMorris AG on May 2, 2024 in Zurich
^
DocMorris AG / Key word(s): General Meeting
Resolutions from the 31st Ordinary General Meeting of DocMorris AG on 2 January
May 2024 in Zurich
02.05.2024 / 18:45 CET/CEST
————————————————– — ———————
Frauenfeld, May 2, 2024
Media release
Resolutions from the 31st Ordinary General Meeting of DocMorris AG on 2 January
May 2024 in Zurich
* The shareholders approved the management report, the annual report and…
Consolidated financial statements for 2023 and the recommendation of the Board of Directors for their use
net income for 2023.
* All members of the Board of Directors and the Group’s Executive Board
Distribution provided.
* All members of the Board of Directors other than those mentioned and
A Salary Committee was appointed for another term until next year
confirmed at the ordinary general meeting.
* Changes to the statutes: Changes to the provisions of the new one
Stock corporation law and the main proposal to change the threshold
Approval was given to include an item on the agenda.
What was added to the Articles of Association also became a condition
Share capital for financing, construction and other purposes
approved.
* Buis Bürgi AG as independent voting representative and Ernst & Young AG
were re-elected as auditors.
* The General Assembly approved the 2023 sustainability report.
* The shareholders also approved the compensation of the Board of Directors
and corporate governance. Mostly based on the recommendations
a voting rights consultant who ensures transparency in the payment system
already condemned before the general meeting
2023 compensation report rejected in consultation vote.
DocMorris will examine this criticism in detail and continue the discussion
Looking for this issue with bigger shareholders to have one next year
Present a widely accepted compensation report.
Contact analysts and investors
Dr. Daniel Grigat, Head of Investor Relations & Sustainability
Email: ir@docmorris.com, Tel: 41 52 560 58 10
Media link
Torben Bonnke, Director of Communications
Email: media@docmorris.com, Phone: +49 171 864 888 1
Agenda
August 20, 2024 Half Year Results 2024 (Conference Call / Webcast)
15. October 2024 Trade Update Q3/2024
Doc Morris
The company Swiss DocMorris AG is based in the United States
Online pharmacy, marketplace and professional healthcare
strong brands in Germany and other European countries. The
Delivery happens mostly from a very automatic
Logistics center in Heerlen, Netherlands with capacity 27
million packages a year. This works in Spain and France
The company is the leading marketplace for health and healthcare in southern Europe
Care products. With its business model, DocMorris offers patients,
Customers and partners of a wide range of products and services.
It follows the vision of creating a digital health ecosystem
where people can manage their health with one click
can The company was changed from Zur Rose Group AG to DocMorris in May 2023
AG renamed after selling its Swiss business to Migros/Medbase
grew. That includes the Swiss industry, approx
1,600 employees in Germany, the Netherlands, Spain, France and
Switzerland has an external conversion of CHF with more than 9 million active customers
1,038 million shares of DocMorris AG are traded on stock exchanges
listed (Valor 4261528, ISIN CH0042615283, ticker DOCM). More
Information at corporate.docmorris.com.
————————————————– — ———————
End of media releases
————————————————– — ———————
Language: German
Company: DocMorris AG
Steps 49
8500 Frauenfeld
Switzerland
ISSN: CH0042615283
Exchange: SIX Swiss Exchange
EQS News Number: 1894643
End of EQS News Service message
————————————————– — ———————
1894643 02.05.2024 CET/CEST
°
2024-05-03 04:49:13
#Resolutions #31st #Ordinary #General #Meeting #DocMorris #Zurich #Germany
